(0.45%) 5 041.06 points
(0.47%) 38 080 points
(0.87%) 15 742 points
(-0.49%) $78.61
(4.92%) $2.03
(-0.12%) $2 308.20
(0.18%) $26.80
(0.75%) $962.05
(0.12%) $0.934
(0.05%) $11.03
(0.15%) $0.800
(-0.14%) $93.13
-1.69% HKD 5.25
Live Chart Being Loaded With Signals
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China...
Stats | |
---|---|
Volumen de hoy | 3.85M |
Volumen promedio | 8.99M |
Capitalización de mercado | 23.74B |
EPS | HKD0 ( 2024-03-25 ) |
Próxima fecha de ganancias | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0.0870 ( 2023-06-01 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.94 |
ATR14 | HKD0.00700 (0.13%) |
Volumen Correlación
Shandong Weigao Group Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shandong Weigao Group Correlación - Moneda/Commodity
Shandong Weigao Group Finanzas
Annual | 2023 |
Ingresos: | HKD13.23B |
Beneficio Bruto: | HKD6.64B (50.21 %) |
EPS: | HKD0.440 |
FY | 2023 |
Ingresos: | HKD13.23B |
Beneficio Bruto: | HKD6.64B (50.21 %) |
EPS: | HKD0.440 |
FY | 2022 |
Ingresos: | HKD13.62B |
Beneficio Bruto: | HKD7.11B (52.23 %) |
EPS: | HKD0.600 |
FY | 2021 |
Ingresos: | HKD13.15B |
Beneficio Bruto: | HKD7.27B (55.27 %) |
EPS: | HKD0.500 |
Financial Reports:
No articles found.
Shandong Weigao Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0960 (N/A) |
HKD0 (N/A) |
HKD0.0870 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00175 | 2004-09-02 |
Last Dividend | HKD0.0870 | 2023-06-01 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | HKD1.546 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.64 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.84 | |
Div. Directional Score | 7.51 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9633.HK | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
2128.HK | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% | |
1126.HK | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
0207.HK | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% | |
3828.HK | Ex Dividend Knight | 2023-09-14 | Annually | 0 | 0.00% | |
1710.HK | Ex Dividend Junior | 2023-09-25 | Annually | 0 | 0.00% | |
0743.HK | Ex Dividend Junior | 2023-07-07 | Annually | 0 | 0.00% | |
2313.HK | Ex Dividend Knight | 2023-09-11 | Semi-Annually | 0 | 0.00% | |
1278.HK | Ex Dividend Junior | 2023-08-28 | Sporadic | 0 | 0.00% | |
0336.HK | Ex Dividend Knight | 2023-09-13 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.151 | 1.500 | 6.97 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0595 | 1.200 | 8.02 | 9.62 | [0 - 0.3] |
returnOnEquityTTM | 0.0900 | 1.500 | -0.111 | -0.166 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.71 | 2.17 | [1 - 3] |
quickRatioTTM | 1.753 | 0.800 | 4.39 | 3.51 | [0.8 - 2.5] |
cashRatioTTM | 0.922 | 1.500 | 5.99 | 8.99 | [0.2 - 2] |
debtRatioTTM | 0.124 | -1.500 | 7.94 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 13.95 | 1.000 | 5.94 | 5.94 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.500 | 1.000 | 5.00 | 5.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.70 | 8.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.268 | 1.000 | 9.62 | 9.62 | [0.2 - 2] |
assetTurnoverTTM | 0.393 | 0.800 | -0.714 | -0.571 | [0.5 - 2] |
Total Score | 10.18 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.95 | 1.000 | 9.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0900 | 2.50 | -0.0713 | -0.166 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.51 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.879 | 1.500 | 7.47 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0844 | 1.000 | -0.389 | 0 | [0.1 - 0.5] |
Total Score | 4.84 |
Shandong Weigao Group
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico